Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 7.97 M7.29 M5.55 M5.62 M8.69 M7.91 M 27.77 M Research & development —————— — Operating income 11.59 M40.26 M17.85 M25.93 M28.27 M-24.82 M 47.23 M Non-Operating Income, Total 650 K626 K616 K635 K622 K612 K 2.48 M Interest expense, net of interest capitalized 28.84 M31.06 M31.13 M28.52 M28.32 M29.19 M 117.16 M Non-Operating Income, excl. Interest Expenses -28.2 M-30.43 M-30.51 M-27.89 M-27.7 M-28.57 M -114.67 M Unusual income/expense —————— — Pretax income 11.77 M14.39 M17.91 M17.18 M14.58 M-55.19 M -5.52 M Equity in earnings —————— — Taxes 2.04 M3.36 M4.32 M4.54 M2.56 M-13.09 M -1.67 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 9.73 M11.03 M13.59 M12.64 M12.02 M-42.1 M -3.85 M Discontinued operations —————— — Net income 9.73 M11.03 M13.59 M12.64 M12.02 M-42.1 M -3.85 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 9.73 M11.03 M13.59 M12.64 M12.02 M-42.1 M -3.85 M Basic earnings per share (Basic EPS) 0.650.730.90.840.79-2.76 -0.23 Diluted earnings per share (Diluted EPS) 0.630.710.880.840.78-2.76 -0.26 Average basic shares outstanding 14.96 M15.03 M15.09 M15.05 M15.18 M15.24 M — Diluted shares outstanding 15.46 M15.45 M15.44 M15.35 M15.42 M15.24 M — EBITDA -11.5 M14.59 M-7.64 M4.29 M6.45 M-42.27 M -39.17 M EBIT -13.05 M12.93 M-9.24 M2.6 M4.77 M-48.67 M -50.54 M Cost of revenue 55.78 M32.21 M56.6 M48.04 M51.4 M92.16 M 248.19 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1.55 M1.67 M1.6 M1.69 M1.67 M6.41 M 11.37 M